Last updated on October 2018

Korean Post-marketing Surveillance for Xeljanz


Brief description of study

The objective of this study is to identify any problems and questions with respect to the safety and efficacy of Xeljanz during the post-marketing period as required by the regulation of MFDS.

Clinical Study Identifier: NCT02984020

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

Chonbuk National University Hospital, Department of Rheumatology
Chonju, Korea, Republic of
  Connect »